Topic 3: Assessment of T-TEER Results and Intra-Procedural Outcomes

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Consultant Fee/Honoraria/Speaker's Bureau - Edwards Lifesciences; GE Healthcare; Medtronic; Valgen; Neochord; Half Moon Medical; Shifamed; Abbott; Nyra; Meocor
• Advisor (not reimbursed) - VDyne; Anteris